Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic Testing.

Journal of the American College of Radiology : JACR - 1 Apr 2017

Rosenthal Eric T, Evans Brent, Kidd John, Brown Krystal, Gorringe Heidi, van Orman Michael, Manley Susan

Abstract excerpt

PURPOSE: Breast MRI screening is recommended for women with a >20% lifetime risk for breast cancer on the basis of estimates derived from risk models dependent largely on family history. Alternatively, a >20% lifetime risk can be established through genetic testing of BRCA1 and BRCA2, as well as a growing selection of other genes associated with inherited breast cancer risk. The aim of this study was to quantify...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Early Detection of Cancer

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Magnetic Resonance Imaging

Share to Patient Selection

Share to Risk Factors

Source

Identifiers

PMID: 28011157
DOI: 10.1016/j.jacr.2016.10.003

Genes

BRCA1
ATM
CHEK2
PALB2
BRCA2
CDH1
PTEN
STK11

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic Testing.PMID 28011157Read ↗

Breast cancer screening implications of risk modeling among female relatives of ATM and CHEK2 carriers.Semantic proximity Read ↗

Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic VariantsSemantic proximity Read ↗

The role of screening MRI in the era of next generation sequencing and moderate-risk genetic mutations.Semantic proximity Read ↗

Risk for breast cancer and management of unaffected individuals with non-BRCA hereditary breast cancer.Semantic proximity Read ↗

Radiographic Surveillance of Patients with Non-BRCA1/2 Pathogenic Variants.Semantic proximity Read ↗

Development and Validation of the PREMMplus Model for Multigene Hereditary Cancer Risk Assessment.Semantic proximity Read ↗

The American Cancer Society guidelines for breast screening with magnetic resonance imaging: an argument for genetic testing.Semantic proximity Read ↗

Genetic Testing and Screening Recommendations for Patients with Hereditary Breast Cancer.Semantic proximity Read ↗

Breast Cancer Risk Modification in Women with Pathogenic Variants in BRCA1, BRCA2, ATM, CHEK2, and PALB2.Semantic proximity Read ↗

Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations.Semantic proximity Read ↗

Risk of Late-Onset Breast Cancer in Genetically Predisposed Women.Semantic proximity Read ↗

Effectiveness and tasks of breast MRI surveillance for high-risk women with cancer susceptibility genes other than BRCA1/2: a single institution study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.